Plaintiffs filed over 350 products liability cases last month in Delaware state court against AstraZeneca Pharmaceuticals over the anti-psychotic drug Seroquel, which is more than the total number of cases filed in AstraZeneca's home state in the last two years. A defense observer thinks that plaintiffs counsel may be trying to force the company into an early settlement of the Delaware cases and to avoid the federal multidistrict litigation. But a defense attorney says AstraZeneca has no plans to settle.
May 09, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Plaintiffs filed more than 350 products liability cases last month in Delaware state court against AstraZeneca Pharmaceuticals L.P. over the anti-psychotic drug Seroquel — a surge exceeding the total number of cases filed there in the last two years.
Plaintiffs lawyers contend that there is nothing behind the spike in filings. They point out that Delaware is Wilmington-based AstraZeneca’s home state and that the cases would have been filed eventually anyway.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
